Our current studies focus on identifying the molecular mechanisms involved in the regulation of SOX2 by CD44 signaling and the role of CD44‐SOX2‐SNAIL/SLUG axis in eliciting EMT and migration/tumor progression. Here, SNAI2 is linked to neoplasm.